Double-digit growth in its proton therapy and dosimetry business segments elevated proton therapy developer Ion Beam Applications (IBA) to greater revenues in the company's first quarter (end-March 31).
Revenues increased 27% to 58.6 million euros ($73.8 million U.S.), compared with
46.3 million euros ($58.3 million U.S.) in the first quarter of 2014.
Backlog in the company's proton therapy and other accelerators segments continues to reach new heights of 278.8 million euros ($351.3 million U.S.) at the end of the first quarter, the company reported.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
